SEVERE INTRAOCULAR PRESSURE ELEVATION FOLLOWING INTRAVITREAL RANIBIZUMAB (LUCENTIS) INJECTION FOR WET AGE-RELATED MACULAR DEGENERATION

被引：0
|
作者：
Reis, Gustavo [1 ]
Schendel, Steven [1 ]
Goldberg, Ivan [1 ,2 ]
Lim, Ridia [1 ,2 ]
Chua, Brian E. [1 ,2 ,3 ]
Lee, Anne [1 ,2 ]
Martins, Alessandra [1 ,2 ]
Higgins, Ralph [1 ,2 ]
Grigg, John [1 ,2 ,4 ]
Clement, Colin I. [1 ,2 ]
机构：
[1] Sydney Eye Hosp, Glaucoma Unit, Sydney, NSW 2000, Australia
[2] Univ Sydney, Cent Clin Sch, Sydney, NSW 2006, Australia
[3] Macquarie Univ, Sch Adv Med, Sydney, NSW 2109, Australia
[4] Save Sight Inst, Sydney, NSW 2000, Australia
来源：
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2013年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [31] Ranibizumab and aflibercept for the treatment of wet age-related macular degeneration
    Yazdi, Mohammad Hossein
    Faramarzi, Mohammad All
    Nikfar, Shekoufeh
    Falavarjani, Khalil Ghasemi
    Abdollahi, Mohammad
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (09) : 1349 - 1358
  • [32] Long-term effects of intravitreal bevacizumab and aflibercept on intraocular pressure in wet age-related macular degeneration
    Kahkonen, Mikael
    Tuuminen, Raimo
    Aaltonen, Vesa
    BMC OPHTHALMOLOGY, 2021, 21 (01)
  • [33] Living with age-related macular degeneration treatment: Patient experiences of being treated with ranibizumab (Lucentis)((R)) intravitreal injections
    Thetford, Clare
    Hodge, Suzanne
    Harding, Simon
    Taylor, Sandra
    Knox, Paul C.
    BRITISH JOURNAL OF VISUAL IMPAIRMENT, 2013, 31 (02) : 89 - 101
  • [34] Long-term effects of intravitreal bevacizumab and aflibercept on intraocular pressure in wet age-related macular degeneration
    Mikael Kähkönen
    Raimo Tuuminen
    Vesa Aaltonen
    BMC Ophthalmology, 21
  • [35] Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
    Garcia-Layana, Alfredo
    Figueroa, Marta S.
    Arias, Luis
    Araiz, Javier
    Maria Ruiz-Moreno, Jose
    Garcia-Arumi, Jose
    Gomez-Ulla, Francisco
    Isabel Lopez-Galvez, Mara
    Cabrera-Lopez, Francisco
    Manuel Garcia-Campos, Jose
    Mones, Jordi
    Cervera, Enrique
    Armada, Felix
    Gallego-Pinazo, Roberto
    JOURNAL OF OPHTHALMOLOGY, 2015, 2015
  • [36] Sustained elevation of intraocular pressure after intravitreal injections of bevacizumab in eyes with neovascular age-related macular degeneration
    Nurit Mathalone
    Anat Arodi-Golan
    Shaul Sar
    Yulia Wolfson
    Mordechai Shalem
    Idit Lavi
    Orna Geyer
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2012, 250 : 1435 - 1440
  • [37] Sustained elevation of intraocular pressure after intravitreal injections of bevacizumab in eyes with neovascular age-related macular degeneration
    Mathalone, Nurit
    Arodi-Golan, Anat
    Sar, Shaul
    Wolfson, Yulia
    Shalem, Mordechai
    Lavi, Idit
    Geyer, Orna
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2012, 250 (10) : 1435 - 1440
  • [38] Comparison between Aflibercept, Ranibizumab intravitreal injection on Neovascular Age-related macular degeneration patients
    Kwon, Y. H.
    Min, J. S.
    Ahn, H.
    ACTA OPHTHALMOLOGICA, 2016, 94
  • [39] Retinal blood flow in response to an intravitreal injection of ranibizumab for neovascular age-related macular degeneration
    Micieli, Jonathan A.
    Tsui, Edmund
    Lam, Wai-Ching
    Brent, Michael H.
    Devenyi, Robert G.
    Hudson, Chris
    ACTA OPHTHALMOLOGICA, 2012, 90 (01) : E13 - E20
  • [40] INTRAVITREAL RANIBIZUMAB INJECTION FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN PHAKIC VERSUS PSEUDOPHAKIC EYES
    Baek, Ji Sun
    Cho, Han Joo
    Cho, Sung Won
    Kim, Chul Gu
    Kim, Jong Woo
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2013, 33 (03): : 467 - 473
12345